Assessment of the influence of citrate concentration on the International Normalized Ratio (INR) determined with twelve reagent-instrument combinations

Thrombosis and Haemostasis

Volumn 80, Issue 2, 1998, Pages 258-262

  Chantarangkul, Veena ^a   Tripodi, Armando ^a,b   Clerici, Marigrazia ^a   Negri, Barbara ^a   Mannucci, Pier Mannuccio ^a  

^a FONDAZIONE IRCCS CA GRANDA OSPEDALE MAGGIORE POLICLINICO   (Italy)

^b NONE   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CITRIC ACID;

ARTICLE; BLOOD CLOTTING TEST; CALIBRATION; CLINICAL TRIAL; CONCENTRATION RESPONSE; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; HUMAN; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; PROTHROMBIN TIME; QUALITY CONTROL;

EID: 0031851147     PISSN: 03406245     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-0037-1615184     Document Type: Article

References (19)

1. WHO Expert Committee on Biological Standardisation. Thirty-third Report. Technical Report Series 687. WHO, Geneva 1983.
2. Kitchen S, Walker ID, Woods TAL, Preston FE. Thromboplastin related differences in the determination of International Normalized Ratio: a cause for concern? Thromb Haemost 1994; 72: 426-9.
3. Holland LJ, Lawrie AS, Hunt BJ. Evidence of discrepant commercial ISI assignment. Blood Coag Fibr 1992; 3: 493-4.
4. van den Besselaar AMHP, Lewis SM, Mannucci PM, Poller L. Status of present and candidate international reference preparations (IRP) of thromboplastin for the prothrombin time. Thromb Haemost 1993; 69: 85.
5. Poller L, Hougthon D, Carroll J. The reliability of the mean normal prothrombin time of fresh plasmas and of the normal value from a lyophilized "normal" plasma in prothrombin time determination. Brit J Haematol 1994; 88: 866-73.
6. Poggio M, van den Besselaar AMHP, van der Velde EA, Bertina RM. The effect of some instruments for prothrombin time testing on the International Sensitivity Index (ISI) of two rabbit tissue thromboplastin reagents. Thromb Haemost 1989; 62: 868-74.
7. Chantarangkul V, Tripodi A, Mannucci PM. The effect of instrumentation on thromboplastin calibration. Thromb Haemost 1992; 67: 588-9.
8. Poller L, Triplett DA, Hirsh J, Carroll J, Clarke K. The value of plasma calibrants in correcting coagulometer effects on International Normalized Ratio. Am J Clin Path 1995; 103: 358-65.
9. Ingram GIC, Hills M. The Prothrombin Time Test: Effect of varying citrate concentration. Thromb Haemost 1976; 36: 230-36.
10. Hermans J, van den Besselaar AMHP, Loeliger EA, van der elde EA. A collaborative calibration study of reference materials for thromboplastins. Thromb Haemost 1983; 50: 712-7.
11. van den Besselaar AMHP. Multicenter study of replacement of the international reference preparation for thromboplastin, rabbit, plain. Thromb Haemost 1993; 70: 794-9.
12. Tripodi A, Chantarangkul V, Negri B, Clerici M, Mannucci PM. International collaborative study for the calibration of a proposed reference preparation for thromboplastin, human recombinant, plain. Thromb Haemost 1998. In press.
13. Duncan EM, Casey CR, Duncan BM, Lloyd JV. Effect of concentration of trisodium citrate anticoagulant on calculation of the International Normalised Ratio and the International Sensitivity Index of thromboplastin. Thromb Haemost 1994; 72: 84-8.
14. Thomson JM, Darby KV, Poller L. Calibration of BCT/441, the ICSH Reference Preparation for Thromboplastin. Thromb Haemost 1986; 55: 379-82.
15. van der Velde EA. Orthogonal regression lines. In: Thromboplastin Calibration and Oral Anticoagulant Control. van den Besselaar AMHP, Gralnick HR, Lewis SM, eds. Boston: Martinus Nijhoff Publishers 1984: pp 25-39.
16. Adcock DM, Kressin DC, Marlar RA. Effect of 3.2% vs. 3.8% sodium citrate concentration on routine coagulation testing. Am J Clin Pathol 1997; 107: 105-10.
17. Poller L, Triplett DA, Hirsh J, Carroll J, Clarke K. The value of plasma calibrants in correcting coagulometer effects on International Normalized Ratios. Am J Clin Path 1995; 103: 358-65.
18. van den Besselaar AMHP. Comparison of lyophilized plasmas with fresh plasmas for calibration of thromboplastin reagents in oral anticoagulant control. Brit J Haemat 1996; 93: 437-44.
19. Guidelines for thromboplastins and plasma used to control oral anticoagulant therapy. In: WHO Expert Committee on Biological Standardization. Forty-eighth report. WHO, Geneva. In press.